Literature DB >> 15681712

Why should we care about palliative care for AIDS in the era of antiretroviral therapy?

P A Selwyn.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15681712      PMCID: PMC1763746          DOI: 10.1136/sti.2004.011585

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


× No keyword cloud information.
  6 in total

1.  Hospital based palliative care in sub-Saharan Africa; a six month review from Malawi.

Authors:  Julia B Tapsfield; M Jane Bates
Journal:  BMC Palliat Care       Date:  2011-07-09       Impact factor: 3.234

2.  Qualitative situational analysis of palliative care for adolescents with cancer and HIV in South Africa: healthcare worker perceptions.

Authors:  Nothando Ngwenya; Julia Ambler; Moherndran Archary
Journal:  BMJ Open       Date:  2019-01-25       Impact factor: 2.692

3.  Palliative care for HIV in the era of antiretroviral therapy availability: perspectives of nurses in Lesotho.

Authors:  Megan E Kell; John D Walley
Journal:  BMC Palliat Care       Date:  2009-08-15       Impact factor: 3.234

4.  Validity of measures of pain and symptoms in HIV/AIDS infected households in resources poor settings: results from the Dominican Republic and Cambodia.

Authors:  Gregory Pappas; R Cameron Wolf; Guy Morineau; Richard Harding
Journal:  BMC Palliat Care       Date:  2006-03-20       Impact factor: 3.234

5.  Integrating tuberculosis and HIV services for people living with HIV: costs of the Zambian ProTEST Initiative.

Authors:  Fern Terris-Prestholt; Lilani Kumaranayake; Rokaya Ginwalla; Helen Ayles; Ignatius Kayawe; Mary Hillery; Peter Godfrey-Faussett
Journal:  Cost Eff Resour Alloc       Date:  2008-01-23

6.  An educational intervention to reduce pain and improve pain management for Malawian people living with HIV/AIDS and their family carers: study protocol for a randomised controlled trial.

Authors:  Kennedy Nkhoma; Jane Seymour; Antony Arthur
Journal:  Trials       Date:  2013-07-13       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.